HIV Treatment Adherence Dose Determination Trial
This study is testing different amounts (doses) of a behavioral counseling program called Behavioral Self-Regulation Adherence Counseling. This program is delivered over the phone and teaches skills to help people with HIV stick to their antiretroviral therapy (ART) treatment. The goal is to find out how much counseling is most effective for improving treatment adherence and reducing the amount of HIV in the blood (viral load). You may be able to join if you are 18 or older, have confirmed HIV, are prescribed ART, and are not consistently taking your medication. You also need access to a phone and the internet. The study will measure changes in your ART adherence and HIV viral load over 12 months to see how well the counseling works.
- Study design
- This is an interventional study with a planned enrollment of 400 participants. The specific phase of the trial is not provided.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your antiretroviral therapy adherence and HIV viral load will be measured at 12 months after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
HIV Treatment Adherence Dose Determination Trial
At a glance
Conditions
Where it's being run
2 sites across 2 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in Antiretroviral Therapy Adherence from Baseline to 12-Months12-Month
Medication adherence defined by percentage of medication doses taken as prescribed
- Change in HIV Viral Load from Baseline to 12-months12-months
Blood plasma HIV RNA